What factors drive China’s proton therapy market?

China is expanding its network of centres across major cities.

The increasing demand for advanced cancer treatments, coupled with substantial investments in healthcare infrastructure, is driving notable growth in China’s proton therapy industry, according to Research and Markets.

“Treatment with proton therapy is one of the fast-growing availed options because this form of treatment provides highly targeted radiation to kill tumours while sparing or reducing the implication of surrounding healthy tissue,” the report said.

To meet rising demands, China is expanding its network of proton therapy centres, with new facilities being constructed in major cities across the country.

Government funding and technological innovations are key drivers of this expansion, positioning proton therapy as a core component of the country’s cancer treatment landscape.

The global market is projected to reach $7.19b by 2033 at a compound annual growth rate of 12.75%.